Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
NEW YORK, Jan. 25, 2016 -- The Nasdaq Stock Market announced today that it will delist the common stock and warrant of Perseon Corporation. Perseon Corporation’s stock was suspended on January 19, 2016 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of THT Heat Transfer Technology, Inc. THT Heat Transfer Technology, Inc.’s stock was suspended on January 14, 2016 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Dex Media, Inc. Dex Media, Inc.’s stock was suspended on January 07, 2016 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock, warrant Class A, and warrant Class B of Methes Energies International Ltd. Methes Energies International Ltd’s stock was suspended on January 07, 2016 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of KaloBios Pharmaceuticals, Inc. KaloBios Pharmaceuticals, Inc.’s stock was suspended on January 13, 2016 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO
